|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.40 DKK | +3.09% |
|
+0.05% | -4.08% |
| 18/05 | Lundbeck's Asedebart Secures Orphan Drug Designation in Japan | MT |
| 18/05 | Lundbeck granted Orphan Drug Designation in Japan for asedebart | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| H. LUNDBECK A/S | Pharmaceuticals Wholesale | +3.09% | +0.05% | -4.08% | +15.38% | - | 621.71Cr |  | | |
- Stock Market
- Equities
- HLUN B Stock
- Charts H. Lundbeck A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition